OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Kazuaki Maruyama, Kyoko Imanaka‐Yoshida
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2617-2617
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41

CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 22

Cardiac fibrogenesis: an immuno-metabolic perspective
Md Monirul Hoque, Joy Olaoluwa Gbadegoye, Fasilat Oluwakemi Hassan, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 5

Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence
Lipeng Shi, Jingwei Deng, Jun He, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176632-176632
Open Access | Times Cited: 5

Characterization of a robust mouse model of heart failure with preserved ejection fraction
Dzmitry Matsiukevich, Attila Kovács, Tiandao Li, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 325, Iss. 2, pp. H203-H231
Closed Access | Times Cited: 14

The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activity
Elisavet Angeli, Maria C. Jordan, Mandy Otto, et al.
Matrix Biology (2024) Vol. 128, pp. 65-78
Closed Access | Times Cited: 5

Iron scavenging and suppression of collagen cross-linking underlie antifibrotic effects of carnosine in the heart with obesity
Islam A. Berdaweel, T. Blake Monroe, Amany A. Alowaisi, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4

Mst1/Hippo signaling pathway drives isoproterenol-induced inflammatory heart remodeling
Xiuling He, Shuai Huang, Chijia Yu, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 9, pp. 1718-1729
Open Access | Times Cited: 4

SGLT2 inhibitors: how do they affect the cardiac cells
Betül Rabia Erdoğan, Ebru Arioglu‐Inan
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 4

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of myocardial infarction
Maryam Zolfaghari Dehkharghani, Safa Mousavi, Nazanin Kianifard, et al.
IJC Heart & Vasculature (2024) Vol. 55, pp. 101529-101529
Closed Access | Times Cited: 4

The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Patryk Skórka, Jakub Piotrowski, Estera Bakinowska, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access

The efficacy and safety of panax quinquefolius saponin for heart failure: a systematic review and meta-analysis
Jing Wang, Tianying Chang, Liang Zheng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Early Potentially Irreversible Cardiac Damage in Fabry Disease Precedes Gb3 Inclusion Body Formation
Chung‐Lin Lee, Pei-Sin Chen, Yu‐Ying Lu, et al.
Canadian Journal of Cardiology (2025)
Closed Access

New insights into Smad3 in cardiac fibrosis
Zhen Gao
Gene (2025) Vol. 952, pp. 149418-149418
Closed Access

Increased neprilysin expression is linked to atrial fibrotic remodeling in cardiovascular surgery patients
Toshiaki Nakajima, Akiko Haruyama, Taira Fukuda, et al.
IJC Heart & Vasculature (2025) Vol. 57, pp. 101647-101647
Closed Access

Hydrogel sensing platforms for monitoring contractility in in vitro cardiac models
Junxiu Lu, Xiatong Pan, Wenhong Zhang, et al.
Nanoscale (2025)
Closed Access

Exercise and tissue fibrosis: recent advances in therapeutic potential and molecular mechanisms
Zheng Zhao, Yongxue Zhu, David Wan
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models
Maria Cardona-Timoner, Rita N. Gomes, Diana S. Nascimento
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3038-3038
Open Access

Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis: research progress and challenges
Qianrong Li, Chunzhen Ren, Bing Jiang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

CircRNAs: versatile players and new targets in organ fibrosis
Lei Wei, Limin Liu, Ming Bai, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11

Understanding Fibroblast Heterogeneity in Form and Function
Jennifer Parker, C. Alexander Valencia, Deena Akras, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2264-2264
Open Access | Times Cited: 11

The development of early human lymphatic vessels as characterized by lymphatic endothelial markers
Shoichiro Yamaguchi, Natsuki Minamide, Hiroshi Imai, et al.
The EMBO Journal (2024) Vol. 43, Iss. 5, pp. 868-885
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top